Author:
Haider Khawaja Husnain,Aramini Beatrice
Abstract
AbstractBone marrow-derived mesenchymal stem cells (MSCs) have successfully progressed to phase III clinical trials successive to an intensive in vitro and pre-clinical assessment in experimental animal models of ischemic myocardial injury. With scanty evidence regarding their cardiogenic differentiation in the recipient patients’ hearts post-engraftment, paracrine secretion of bioactive molecules is being accepted as the most probable underlying mechanism to interpret the beneficial effects of cell therapy. Secretion of small non-coding microRNA (miR) constitutes an integral part of the paracrine activity of stem cells, and there is emerging interest in miRs’ delivery to the heart as part of cell-free therapy to exploit their integral role in various cellular processes. MSCs also release membrane vesicles of diverse sizes loaded with a wide array of miRs as part of their paracrine secretions primarily for intercellular communication and to shuttle genetic material. Exosomes can also be loaded with miRs of interest for delivery to the organs of interest including the heart, and hence, exosome-based cell-free therapy is being assessed for cell-free therapy as an alternative to cell-based therapy. This review of literature provides an update on cell-free therapy with primary focus on exosomes derived from BM-derived MSCs for myocardial repair.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry, Genetics and Molecular Biology (miscellaneous),Molecular Medicine,Medicine (miscellaneous)
Reference142 articles.
1. Haider HK. Bone marrow cell therapy and cardiac reparability: better cell characterization will enhance clinical success. Regen Med. 2018;13:457–75.
2. Haider HK, Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol-Heart and Circulatory Physi. 2005;288(6):H2557–67.
3. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, Marx G, et al. Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res. 2005;65(1):52–63.
4. Scherschel JA, Soonpaa MH, Srour EF, Field LJ, Rubart M. Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardium. Mol Ther. 2008;16(6):1129–37.
5. Haider HKh, Aslam M. Cell-free therapy with stem cell secretions: protection, repair and regeneration of the injured myocardium. In: From hype to real hope (Ed. Haider HKh & Aziz S), DeGruyter, 2018; pp34–70.
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献